文献速递支持与姑息治疗

2001-10年国际儿童癌症发病率:一项基于人群的登记研究

International incidence of childhood cancer, 2001-10: a population-based registry study.
PubMed 文献 · Lancet Oncol · 2017-04-11

该研究由国际癌症研究机构与国际癌症登记协会合作,基于62个国家和地区153个高质量癌症登记处2001-10年数据,纳入0-19岁385509例新发儿童癌症病例。0-14岁世界标化发病率为140.6/百万,最常见为白血病(46.4),全球发病率自1980年代124.0升至140.6,地区、种族、年龄和性别间差异需持续监测。

要点

  • 0-14岁儿童总体世界标化发病率为140.6/百万,白血病最常见(46.4),其次中枢神经系统肿瘤(28.2)和淋巴瘤(15.2)。
  • 15-19岁青少年发病率185.3/百万,淋巴瘤(41.8)和上皮肿瘤及黑色素瘤(39.5)最常见。
  • 自1980年代以来,0-14岁儿童全球登记癌症世界标化发病率从124.0升至140.6/百万。

核心结论

  • 该全球儿童癌症发病率数据将用于病因学研究并为公共卫生政策提供信息,可能有助于实现可持续发展目标的若干具体目标。
  • 观察到的地区、种族和民族、年龄、性别及时间变化需要持续监测和研究。

研究设计与样本

  • 由国际癌症研究机构与国际癌症登记协会合作开展的基于人群的登记研究。
  • 收集高质量癌症登记处覆盖人群中2001-10年诊断的20岁前所有恶性肿瘤及中枢神经系统非恶性肿瘤。
  • 532个受邀癌症登记处中153个来自62个国家、部门和地区符合质量标准并贡献2001-10整十年数据。
  • 采用世界标准人口对0-14岁和0-19岁年龄组发病率进行年龄标准化(WSR),使用各年龄组(0-4、5-9、10-14、15-19岁)年龄别发病率(ASR)。

主要发现

  • 0-14岁儿童总体WSR为140.6/百万(基于284649例),最常见为白血病(WSR 46.4),其次中枢神经系统肿瘤(WSR 28.2)和淋巴瘤(WSR 15.2)。
  • 15-19岁青少年(基于100860例)ASR为185.3/百万,最常见为淋巴瘤(ASR 41.8)和上皮肿瘤及黑色素瘤组(ASR 39.5)。
  • 发病率在所描述区域之间和内部以及按癌症类型、性别、年龄、种族和民族组别差异显著。
  • 自1980年代以来,0-14岁儿童全球登记癌症WSR从124.0(95% CI 123.3-124.7)升至140.6(140.1-141.1)/百万。

临床怎么用

  • 该全球儿童癌症发病率数据将用于病因学研究并为公共卫生政策提供信息,可能有助于实现可持续发展目标的若干具体目标。
  • 观察到的地区、种族和民族、年龄、性别及时间变化需要持续监测和研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer is a major cause of death in children worldwide, and the recorded incidence tends to increase with time. Internationally comparable data on childhood cancer incidence in the past two decades are scarce. This study aimed to provide internationally comparable local data on the incidence of childhood cancer to promote research of causes and implementation of childhood cancer control. METHODS: This population-based registry study, devised by the International Agency for Research on Cancer in collaboration with the International Association of Cancer Registries, collected data on all malignancies and non-malignant neoplasms of the CNS diagnosed before age 20 years in populations covered by high-quality cancer registries with complete data for 2001-10. Incidence rates per million person-years for the 0-14 years and 0-19 years age groups were age-adjusted using the world standard population to provide age-standardised incidence rates (WSRs), using the age-specific incidence rates (ASR) for individual age groups (0-4 years, 5-9 years, 10-14 years, and 15-19 years). All rates were reported for 19 geographical areas or ethnicities by sex, age group, and cancer type. The regional WSRs for children aged 0-14 years were compared with comparable data obtained in the 1980s. FINDINGS: Of 532 invited cancer registries, 153 registries from 62 countries, departments, and territories met quality standards, and contributed data for the entire decade of 2001-10. 385 509 incident cases in children aged 0-19 years occurring in 2·64 billion person-years were included. The overall WSR was 140·6 per million person-years in children aged 0-14 years (based on 284 649 cases), and the most common cancers were leukaemia (WSR 46·4), followed by CNS tumours (WSR 28·2), and lymphomas (WSR 15·2). In children aged 15-19 years (based on 100 860 cases), the ASR was 185·3 per million person-years, the most common being lymphomas (ASR 41·8) and the group of epithelial tumours and melanoma (ASR 39·5). Incidence varied considerably between and within the described regions, and by cancer type, sex, age, and racial and ethnic group. Since the 1980s, the global WSR of registered cancers in children aged 0-14 years has increased from 124·0 (95% CI 123·3-124·7) to 140·6 (140·1-141·1) per million person-years. INTERPRETATION: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals. The observed geographical, racial and ethnic, age, sex, and temporal variations require constant monitoring and research. FUNDING: International Agency for Research on Cancer and the Union for International Cancer Control.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017. PMID: 28410997. doi:10.1016/S1470-2045(17)30186-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。